IPSC stock · PG stock

IPSC vs PG

Century Therapeutics Inc (IPSC) versus Procter & Gamble Company (PG) — a side-by-side from cached financials, not a winner call.

Century Therapeutics Inc (IPSC) is a biotechnology company listed on US.

Procter & Gamble Company (PG) is a household & personal products company listed on US. It is led by Jon Moeller.

Latest reported IPSC revenue for 2024-12-31 was $6.6M. Net income was -$126.6M. Revenue was up 194.8% from 2023-12-31 to 2024-12-31. IPSC currently screens at market cap $47.8M.

Latest reported PG revenue for 2025-06-30 was $84.28B. Net income was $15.97B. PG currently screens at market cap $373.53B and trailing P/E 25.3.

IPSC currently screens at market cap $47.8M. PG currently screens at market cap $373.53B and trailing P/E 25.3.

Not investment advice. Open the IPSC and PG stock pages for the full models.

Not investment advice.

Popular Stock Comparisons